Sites can strengthen their position by approaching feasibility strategically, investing in clear communication, and being ...

Veristat has announced its intended acquisition of Certara's Regulatory and Medical Writing business, a move that will add ...

In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, makes the case ...

The FDA has granted accelerated approval to lunsotogene parvec-cwha (Otarmeni), an adeno-associated virus (AAV) vector–based ...

Partner at Global Life Sciences Alliance (GLSA), where she works across sponsors, CROs, and research sites to support study feasibility, site selection, and clinical trial execution. Her work focuses ...

Partner at Global Life Sciences Alliance (GLSA) and brings over 30 years of experience in the life sciences and clinical research industry. He has worked extensively across research sites, CROs, and ...

In today's ACT Brief, we explore organizational factors behind CRL decisions, methodological concerns with pooling amyloid ...

In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, discusses how ...

Oral semaglutide lowered HbA1c vs placebo in a phase 3 trial in adolescents with type 2 diabetes, pending full data and ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, explains why the most consequential shift in clinical trial design is ...

In this video interview, Mark Freitas, managing director and life sciences practice lead at Alvarez & Marsal, explains why ...